Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Wang D, Quiros J, Mahuron K, Pai CC, Ranzani V, Young A, Silveria S, Harwin T, Abnousian A, Pagani M, Rosenblum MD, Van Gool F, Fong L, Bluestone JA, DuPage M

Publication

Cell reports

Publication ID (Profile URL)

https://researcherprofiles.org/profile/14389021

Publication Year

2018

PubMed ID

29898397

Publication Title

Wang D, Quiros J, Mahuron K, Pai CC, Ranzani V, Young A, Silveria S, Harwin T, Abnousian A, Pagani M, Rosenblum MD, Van Gool F, Fong L, Bluestone JA, DuPage M. Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity. Cell Rep. 2018 06 12; 23(11):3262-3274.